No Data
No Data
No Data
Novo to Test If GLP-1 Weight Loss Drugs Can Help Curb Addiction
Novo Nordisk Launches NovoCare Rivaling Eli Lilly's LillyDirect
FDA to Spare Compounders as Novo Nordisk's Ozempic Supply Begins to Improve
Hims & Hers Plunges as the FDA Says Novo's Weight Loss Drugs Are Not in Shortage
NOVO NORDISK A/S To Go Ex-Dividend On March 28th, 2025 With 1.19131 USD Dividend Per Share
Hims & Hers Jumps Ahead of Controversial Super Bowl Commercial
Unlock the Full List